Pfizer Inc (PFE)

Debt-to-assets ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	61,538,000	32,884,000	36,195,000	37,133,000	35,955,000
Total assets	US$ in thousands	227,000,000	197,000,000	181,000,000	154,229,000	167,594,000
Debt-to-assets ratio		0.27	0.17	0.20	0.24	0.21

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $61,538,000K ÷ $227,000,000K
= 0.27

The debt-to-assets ratio for Pfizer Inc. has fluctuated over the past five years, ranging from 0.18 to 0.32. In 2023, the ratio increased to 0.32 from 0.18 in the previous year, indicating that a higher proportion of Pfizer's assets are financed through debt. This suggests that Pfizer may have taken on more debt relative to its assets in the most recent year. Despite the increase, the debt-to-assets ratio remains below 1, indicating that Pfizer's assets still predominantly finance its operations rather than debt. It is important for investors and stakeholders to monitor this ratio to assess Pfizer's leverage and financial risk over time.